1.
Blood Cancer Discov
; 2(1): 13-18, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: covidwho-20238332
RESUMEN
Cancer vaccine development has been historically fraught with difficulty, but tremendous progress has been made over the past 5 years. In this In Focus article, we reflect on the progress and challenges with vaccine development for cancers in general and for hematologic malignancies in particular, and suggest how our cancer vaccine experience can offer insight into COVID-19 vaccination.